Despite losses and negative cash flow, the company's US$178....
Despite losses and negative cash flow, the company's US$178.2m balance sheet allows for at least two years of growth spending. However, the stock is seen as risky due to these financial conditions.
Is Tandem Diabetes Care (NASDAQ:TNDM) Using Debt In A Risky Way?
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment